Fundz

Tolemy Bio secures €1.4M in pre-seed funding to enhance its AI-driven cell biology research technology, led by Norrsken Evolve.

PRIVATEMay 12, 2026

Amount Raised

€1.4 Million

Round Type

Pre-Seed

Cambridge

Investors

Big Sur VenturesJME VenturesMasiaA New UK Based Stealth FundNorrsken Evolve

Description

Cambridge-based Tolemy Bio has raised €1.4 million in pre-seed funding to advance its AI-enabled technology for cell biology research. The funding will be used to expand data generation and machine learning capabilities, as well as support early customer deployments. The round was led by Norrsken Evolve with participation from multiple investors. Tolemy Bio aims to optimize the fragmented workflows in biopharma and cell biology using its platform, Orbit.

Who to call at Tolemy Bio, and when

A new round usually means Tolemy Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tolemy Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tolemy Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tolemy Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tolemy Bio

Location

Cambridge, England, United Kingdom

About

Tolemy Bio is a biotech startup that focuses on AI-enabled technology for cell biology research and biopharma development. The company is developing Orbit, a system designed to help researchers better understand and optimize living cells used in modern therapies. Tolemy Bio aims to streamline experimental workflows, which are currently fragmented and manual, to enhance the application of AI tools in drug development. The company's ultimate goal is to create a virtual-cell platform that facilitates more precise and data-driven experimentation in biopharma.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tolemy Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlex W., Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Tolemy Bio's next move

See what Strategic adds

Tolemy Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.